Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Clinical metagenomics assessments improve diagnosis and outcomes in community-acquired pneumonia

Fig. 2

Diagnostic performance of mNGS assay for pathogen detection. a Rates of pathogen detection in the control and mNGS groups, summarized from testing with all collected samples; (b) Consistency between mNGS test results and clinical diagnosis; (c) Culture and mNGS detection rates for pathogens in mNGS group; (d) Differential spectrums of bacterial and fungal organisms identified between mNGS and culture; (e) Numbers of specific organisms identified by mNGS and the percentages of each microbial type; (f) Patients with single and multiple pathogens as identified by mNGS; (g) Types of pathogens shown in panel F; (h) Concordance in mNGS results between paired BALF and blood specimens. n.s., not significant, * indicates P < 0.05, ** indicates P < 0.01, *** indicates P < 0.001 by chi-square test

Back to article page